Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Complete cytogenetic remission in a patient with myelodysplastic syndrome during 13-cis-retinoic acid therapy: inhibition of proliferation of the malignant monocytoid clone

Complete cytogenetic remission in a patient with myelodysplastic syndrome during 13-cis-retinoic acid therapy: inhibition of proliferation of the malignant monocytoid clone. Blood. 1986; 67:1322-7.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.